Literature DB >> 11145386

The Harrington reconstruction for advanced periacetabular metastatic destruction: good outcome in 32 patients.

J Nilsson1, P Gustafson, P Fornander, E Ornstein.   

Abstract

We report the outcome in 32 patients operated on for advanced periacetabular metastatic destruction, where all but 2 had Harrington class III destruction. The patients were operated on using the Harrington reconstruction technique, where threaded pins and cement and a total hip replacement are used to reconstruct the acetabulum and ilium. The median survival was 11 (0-106+) months. 13 patients lived for a year or more. At follow-up after 1 year, 10 of the 13 were free of pain at rest and weight-bearing, 6 were walking with and 7 without support, and 11 lived outside a health care facility. 2 patients died within 2 weeks of surgery, both of excessive peroperative bleeding. 2 patients had dislocations, 1 developed a deep infection, and 2 patients deep vein thrombosis. There were no complications caused by erroneous pin placement or intraoperative thromboembolic incidents. There were no mechanical failures, or radiographic signs of loosening, of the pelvic components. The Harrington reconstruction technique is an effective and long-lasting method to relieve pain and restore function in patients with advanced periacetabular metastatic destruction.

Entities:  

Mesh:

Year:  2000        PMID: 11145386     DOI: 10.1080/000164700317362226

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  13 in total

1.  The anatomy of proximal femoral autografts for pelvic reconstruction: a cadaveric study.

Authors:  Shoufeng Wang; Jin Xiong; Chaoshuang Zhan; Aiguo Wang; Yixin Chen; Qing Jiang; Yong Qiu
Journal:  Surg Radiol Anat       Date:  2011-12-03       Impact factor: 1.246

2.  The modified Harrington procedure for metastatic peri-acetabular bone destruction.

Authors:  Ines Vielgut; Patrick Sadoghi; Markus Gregori; Florian M Kovar; Karin Pichler; Werner Maurer-Ertl; Andreas Leithner
Journal:  Int Orthop       Date:  2013-06-12       Impact factor: 3.075

3.  CORR Insights®: Is an Acetabular Cage and Cement Fixation Sufficiently Durable for the Treatment of Destructive Acetabular Metastases?

Authors:  Benjamin K Potter
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

4.  Surgical technique: Porous tantalum reconstruction for destructive nonprimary periacetabular tumors.

Authors:  Fazel A Khan; Peter S Rose; Michiro Yanagisawa; David G Lewallen; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2011-10-12       Impact factor: 4.176

5.  Is an Acetabular Cage and Cement Fixation Sufficiently Durable for the Treatment of Destructive Acetabular Metastases?

Authors:  Philip Rowell; Martin Lowe; Scott Sommerville; Ian Dickinson
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

6.  Jig-assisted modified Harrington reconstruction for metastatic bone destruction of the acetabulum.

Authors:  Raja Bhaskara Rajasekaran; Muhammad Ather Siddiqi; Duncan Whitwell
Journal:  Int Orthop       Date:  2022-01-06       Impact factor: 3.075

Review 7.  The surgical treatment of pelvic bone metastases.

Authors:  Daniel A Müller; Rodolfo Capanna
Journal:  Adv Orthop       Date:  2015-02-24

8.  Outcome after Surgery for Metastases to the Pelvic Bone: A Single Institutional Experience.

Authors:  Chandra Kumar Krishnan; Ilkyu Han; Han-Soo Kim
Journal:  Clin Orthop Surg       Date:  2017-02-13

9.  Comparison of Porous Tantalum Acetabular Implants and Harrington Reconstruction for Metastatic Disease of the Acetabulum.

Authors:  Matthew T Houdek; Peter C Ferguson; Matthew P Abdel; Anthony M Griffin; Mario Hevesi; Kevin I Perry; Peter S Rose; Jay S Wunder; David G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2020-07-15       Impact factor: 6.558

10.  Reconstruction of metastatic acetabular defects using a modified Harrington procedure.

Authors:  Panagiotis Tsagozis; Rikard Wedin; Otte Brosjö; Henrik Bauer
Journal:  Acta Orthop       Date:  2015-07-28       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.